The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
A definitive model for predicting absolute risk of coronary heart disease (CHD) in male and female people with Type II diabetes is not yet available. This paper provides an equation for estimating the risk of new CHD events in people with Type II diabetes, based on data from 4540 U.K. Prospective Diabetes Study male and female patients. Unlike previously published risk equations, the model is diabetes-specific and incorporates glycaemia, systolic blood pressure and lipid levels as risk factors, in addition to age, sex, ethnic group, smoking status and time since diagnosis of diabetes. All variables included in the final model were statistically significant (P<0.001, except smoking for which P=0.0013) in likelihood ratio testing. This model provides the estimates of CHD risk required by current guidelines for the primary prevention of CHD in Type II diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The lower the CAD risk, the higher the chance of a false positive”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [248]
In the citing paper
“During the entire follow-up period, the rate of death among patients in the conventionaltherapy group was 50%, a finding that underscores the poor prognosis for such patients in the absence of intensive treatment.20”
From Effect of a multifactorial intervention on mortality in type 2 diabetes (2008) · cites this paper as [20]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Self-citationStratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Self-citationPrevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Cited by
Items 101–200 of 1,000
Koehestanie, P., de Jonge, C., Berends, F. J., Janssen, I. M., Bouvy, N. D., & Greve, J. W. M. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000794 · Cited by 152
Gillett, M., Royle, P., Snaith, A., Scotland, G., Poobalan, A., Imamura, M., Black, C., Boroujerdi, M., Jick, S., Wyness, L., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16330 · Cited by 146
Laraia, B. A., Karter, A. J., Warton, E. M., Schillinger, D., Moffet, H. H., & Adler, N. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2011.11.036 · Cited by 140
From Atherosclerotic Plaque to Myocardial Infarction—The Leading Cause of Coronary Artery Occlusion
Młynarska, E., Czarnik, W., Fularski, P., Hajdys, J., Majchrowicz, G., Stabrawa, M., Rysz, J., & Franczyk, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137295 · Cited by 191
“The ADVANCE risk score predicts 10-year CVD risk, while the UKPDS predicts fatal and non-fatal CVD risk [50,51].”
BackgroundCost-Effectiveness of Intensified Versus Conventional Multifactorial Intervention in Type 2 Diabetes
Gæde, P., Valentine, W. J., Palmer, A. J., Tucker, D. M. D., Lammert, M., Parving, H.-H., & Pedersen, O. (2008) · Diabetes Care · doi:10.2337/dc07-2452 · Cited by 147
“Risk adjustment for cardiovascular events according to patient age was performed using the risk regression function reported by the UK Prospective Diabetes Study (UKPDS) for first myocardial infarction (13) and was calculated for stroke using data from the UKPDS stroke risk engine (14).”
MethodA Machine Learning Approach to Improving Dynamic Decision Making
Meyer, G., Adomavicius, G., Johnson, P. E., Elidrisi, M., Rush, W. A., Sperl-Hillen, J. M., & O'Connor, P. J. (2014) · Information Systems Research · doi:10.1287/isre.2014.0513 · Cited by 135
“Therefore, we quantify the disutility resulting from not being at goal by calculating the risk of such an event over a 10-year horizon using the UKPDS Risk Engine (Stevens et al. 2001) and applying Monte Carlo simulation to translate the risk estimate into events for the 10,000 simulated patients.”
MethodSimonson, D. C., Halperin, F., Foster, K., Vernon, A., & Goldfine, A. B. (2018) · Diabetes Care · doi:10.2337/dc17-0487 · Cited by 136
Simmons, R. K., Coleman, R. L., Price, H. C., Holman, R. R., Khaw, K.-T., Wareham, N. J., & Griffin, S. J. (2009) · Diabetes Care · doi:10.2337/dc08-1918 · Cited by 146
“The predictive ability of both the UKPDS and Framingham risk equations in the EPIC-Norfolk cohort is lower than that reported in the original populations in which they were developed (11,14).”
MethodPrediction of Coronary Heart Disease in Middle-Aged Adults With Diabetes
Folsom, A. R., Chambless, L. E., Duncan, B. B., Gilbert, A. C., Pankow, J. S., & the Atherosclerosis Risk in Communities Study Investigators (2003) · Diabetes Care · doi:10.2337/diacare.26.10.2777 · Cited by 142
“(3), derived from diabetic participants”
BackgroundShah, S. S., Todkar, J. S., Shah, P. S., & Cummings, D. E. (2010) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.08.009 · Cited by 138
Optimizing the therapeutic benefits of exercise in Type 2 diabetes
Praet, S. F. E., & van Loon, L. J. C. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00566.2007 · Cited by 134
“uk/) can be of help to calculate an individual patient’s risk for coronary heart disease (118).”
BackgroundPalmer, A. J., Clarke, P., Gray, A., Leal, J., Lloyd, A., Grant, D., Palmer, J., FOOS, V., Lamotte, M., Hermann, W., et al. (2013) · Value in Health · doi:10.1016/j.jval.2013.01.002 · Cited by 148
“[15] Stevens RJ, Kothari V, Adler AI, et al.”
BackgroundLackland, D. T., Elkind, M. S. V., D'Agostino, R., Dhamoon, M. S., Goff, D. C., Higashida, R. T., McClure, L. A., Mitchell, P. H., Sacco, R. L., Sila, C. A., et al. (2012) · Stroke · doi:10.1161/str.0b013e31825bcdac · Cited by 135
Exercise therapy in Type 2 diabetes
Praet, S. F. E., & van Loon, L. J. C. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0129-0 · Cited by 128
“uk) may be of help to calculate an individual patient’s risk for coronary heart disease [251].”
BackgroundPeripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus
Brownrigg, J. R. W., de Lusignan, S., McGovern, A., Hughes, C., Thompson, M. M., Ray, K. K., & Hinchliffe, R. J. (2014) · Heart · doi:10.1136/heartjnl-2014-305657 · Cited by 130
“6 However, those data preceded the wide-spread use of statins and renin angiotensin blockade that signi fi cantly reduce the CV risk among those with diabetes.”
RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017
Bajaj, S. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0604-7 · Cited by 125
Chubb, S. A. P., Davis, W. A., & Davis, T. M. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0298 · Cited by 129
Predicting Macro- and Microvascular Complications in Type 2 Diabetes
Tanaka, S., Tanaka, S., Iimuro, S., Yamashita, H., Katayama, S., Akanuma, Y., Yamada, N., Araki, A., Ito, H., Sone, H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0958 · Cited by 128
for the ADVANCE Collaborative Group, Kengne, A. P., Patel, A. A., Colagiuri, S., Heller, S. R., Hamet, P., Marre, M., Pan, C., Zoungas, S., Grobbee, D. E., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1681-4 · Cited by 141
Type 2 diabetes and cardiovascular disease in women
Norhammar, A., & Schenck-Gustafsson, K. G. (2012) · Diabetologia · doi:10.1007/s00125-012-2694-y · Cited by 136
“In patients with diabetes, the UKPDS risk engine is available [43].”
BackgroundA critical review of mathematical models and data used in diabetology
Boutayeb, A., & Chetouani, A. (2006) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-5-43 · Cited by 126
A Computer Simulation Model of Diabetes Progression, Quality of Life, and Cost
Zhou, H., Isaman, D. J. M., Messinger, S., Brown, M. B., Klein, R., Brandle, M., & Herman, W. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2856 · Cited by 121
Simpson, S. H., Majumdar, S. R., Tsuyuki, R. T., Lewanczuk, R. Z., Spooner, R., & Johnson, J. A. (2011) · Diabetes Care · doi:10.2337/dc10-1294 · Cited by 120
“We also measured the change in predicted 10-year risk of cardiovascular disease using the UK Prospective Diabetes Study (UKPDS) Risk Engine (19).”
InfluentialBalducci, S., Zanuso, S., Cardelli, P., Salvi, L., Bazuro, A., Pugliese, L., Maccora, C., Iacobini, C., Conti, F. G., Nicolucci, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049297 · Cited by 123
Kim, W. Y., Astrup, A. S., Stuber, M., Tarnow, L., Falk, E., Botnar, R. M., Simonsen, C., Pietraszek, L., Hansen, P. R., Manning, W. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.633339 · Cited by 129
“Statins, n (%) 20 ( 27 ) 36 (57) 0.001 Aspirin, n (%) 19 (26) 45 (71) 0.001 Patients receiving AHT, n (%) 33 (45) 59 (93) 0.001 Average AHT drugs per patient, n 0.81.2 2.31.2 0.001 BMI indicates body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very-low-density lipoprotein; and AHT, a…”
InfluentialIncremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus
Liu, J.-H., Chen, Y., Yuen, M. M. A., Zhen, Z., Chan, C. W., Lam, K. S. L., Tse, H., & Yiu, K. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0333-5 · Cited by 123
“and cardiovascular events To better risk stratify patients with T2DM, prior studies have developed scoring systems based on HbA1c levels and clinical demographics [13–15].”
BackgroundA mathematical model for the burden of diabetes and its complications
Boutayeb, A., Twizell, E., Achouayb, K., & Chetouani, A. (2004) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-3-20 · Cited by 119
“The literature dealing with modeling for diabetes is mainly concerned with glucose and insulin dynamics [6,18-20], the epidemiology of the disease [21-23] and economic cost and risk models [24-29].”
BackgroundSmith, S. A., Shah, N. D., Bryant, S. C., Christianson, T. J. H., Bjornsen, S. S., Giesler, P. D., Krause, K. H., Erwin, P. J., & Montori, V. M. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.7.747 · Cited by 123
A Review of Emerging Technologies for the Management of Diabetes Mellitus
Zarkogianni, K., Litsa, E., Mitsis, K., Wu, P.-Y., Kaddi, C. D., Cheng, C.-W., Wang, M. D., & Nikita, K. S. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2470521 · Cited by 112
Development and Validation of a Total Coronary Heart Disease Risk Score in Type 2 Diabetes Mellitus
Yang, X., So, W., Kong, A. P. S., Ronald, C. W., Ko, G. T. C., Ho, C. S., Lam, C. W. K., Cockram, C. S., Chan, J. C. N., & Tong, P. C. Y. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.10.019 · Cited by 122
Jones, P. J., Senanayake, V. K., Pu, S., Jenkins, D. J., Connelly, P. W., Lamarche, B., Couture, P., Charest, A., Baril-Gravel, L., West, S. G., et al. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.081133 · Cited by 115
Wolsk, E., Claggett, B. L., Pfeffer, M. A., Díaz, R., Dickstein, K., Gerstein, H. C., Lawson, F. C., Lewis, E. F., Maggioni, A. P., McMurray, J. J. V., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004743 · Cited by 121
Davis, T. M. E., Coleman, R. L., & Holman, R. R. (2013) · Circulation · doi:10.1161/circulationaha.112.000908 · Cited by 128
Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults
Hoerger, T. J., Hicks, K. A., Sorensen, S. W., Herman, W. H., Ratner, R. E., Ackermann, R. T., Zhang, P., & Engelgau, M. M. (2007) · Diabetes Care · doi:10.2337/dc07-0885 · Cited by 111
Can a Chronic Care Model Collaborative Reduce Heart Disease Risk in Patients with Diabetes?
Vargas, R. B., Mangione, C. M., Asch, S., Keesey, J., Rosen, M., Schonlau, M., & Keeler, E. B. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0072-5 · Cited by 108
“This equation is a diabetes-specific formula which estimates the risk of new coronary heart disease events in people with type-2 diabetes based on their mutable characteristics of glycosylated hemoglobin, systolic blood pressure, total cholesterol/HDL cholesterol ratio, smoking status, and immutable characteristics of…”
Huang, E. S., Zhang, Q., Brown, S. E. S., Drum, M. L., Meltzer, D. O., & Chin, M. H. (2007) · Health Services Research · doi:10.1111/j.1475-6773.2007.00734.x · Cited by 118
“However, observational studies demonstrate an association between glucose levels and cardiovascular events (Stevens et al. 2001).”
BackgroundMethodThe Metabolic Syndrome: Concepts and Controversy
Johnson, L. W., & Weinstock, R. S. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.12.1615 · Cited by 127
Quality of Diabetes Care in the Middle- and High-Income Group Populace
Nagpal, J., & Bhartia, A. (2006) · Diabetes Care · doi:10.2337/dc06-0783 · Cited by 109
Cardiovascular Risk After Bariatric Surgery for Obesity
Batsis, J. A., Sarr, M. G., Collazo-Clavell, M. L., Thomas, R. J., Romero-Corral, A., Somers, V. K., & Lopez-Jimenez, F. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.040 · Cited by 108
Ritsinger, V., Malmberg, K., Mårtensson, A., Rydén, L., Wedel, H., & Norhammar, A. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70088-9 · Cited by 118
Dziopa, K., Asselbergs, F. W., Gratton, J., Chaturvedi, N., & Schmidt, A. F. (2022) · Diabetologia · doi:10.1007/s00125-021-05640-y · Cited by 96
Guzder, R., Gatling, W., Mullee, M., & Byrne, C. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0063-9 · Cited by 114
“Europe [21–24].”
Intensive Integrated Therapy of Type 2 Diabetes
Gæde, P., & Pedersen, O. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s39 · Cited by 108
“Average risk factor profiles for patients in the intensive therapy group at baseline and at the end of the study have been calculated, thus giving an opportunity to differentiate the cardiovascular risk reduction into each of the entered variables (29).”
BackgroundDu, Y., Heidemann, C., Rosario, A. S., Buttery, A. K., Paprott, R., Neuhauser, H. K., Riedel, T., Icks, A., & Scheidt‐Nave, C. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000135 · Cited by 107
“For those without CVD, we calculated the 10-year UK Prospective Diabetes Study (UKPDS) CVD risk in per cent using the original version which considers patients’ age, sex, HbA1c, BP, TC, smoking status, and other risk factors.(22) CKD was defined according to the International Society of Nephrology(23) based on an esti…”
MethodPadwal, R. S., Hemmelgarn, B. R., McAlister, F. A., McKay, D. W., Grover, S. A., Wilson, T. W., Penner, B., Burgess, E. D., Bolli, P., Hill, M. D., et al. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70797-3 · Cited by 118
Saba, L., Jamthikar, A. D., Gupta, D., Khanna, N. N., Višković, K., Suri, H. S., Gupta, A. K., Mavrogeni, S. I., Turk, M., Laird, J. R., et al. (2020) · International Angiology · doi:10.23736/s0392-9590.19.04267-6 · Cited by 108
Manley, S. (2003) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2003.182 · Cited by 105
Diabetes and Coronary Heart Disease: A Risk Factor for the Global Epidemic
Chiha, M., Njeim, M., & Chedrawy, E. G. (2012) · International Journal of Hypertension · doi:10.1155/2012/697240 · Cited by 117
“Such tools are available online and include the Framingham risk calculator [39], the UK Prospective Diabetes Study risk engine [40] and the ADA’s Diabetes Personal Health Decisions [41].”
MethodTrends in the Risk for Coronary Heart Disease Among Adults With Diagnosed Diabetes in the U.S.
Ford, E. S. (2011) · Diabetes Care · doi:10.2337/dc10-2251 · Cited by 105
van der Heijden, A. A. W. A., Ortegon, M. M., Niessen, L. W., Nijpels, G., & Dekker, J. M. (2009) · Diabetes Care · doi:10.2337/dc09-0745 · Cited by 108
“Estimated 10-year first CHD risk was calculated for each participant using the Framingham (5) and UKPDS (7) algorithms.”
MethodEffective diabetes care: a need for realistic targets
Winocour, P. H. (2002) · BMJ · doi:10.1136/bmj.324.7353.1577 · Cited by 110
The FIELD Study Investigators (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-13 · Cited by 103
Community based yoga classes for type 2 diabetes: an exploratory randomised controlled trial
Skoro-Kondza, L., Tai, S. S., Gadelrab, R., Drincevic, D., & Greenhalgh, T. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-33 · Cited by 94
“Secondary outcome measures (predefined before the study began) were UKPDS cardiovascular risk score (a composite of blood pressure, smoking status, lipid ratio, presence of atrial fibrillation, and HbA1c which has high predictive value in diabetes),[12] and three candidate psychometric scales: quality of life (using t…”
MethodPrecision prognostics for the development of complications in diabetes
Schiborn, C., & Schulze, M. B. (2022) · Diabetologia · doi:10.1007/s00125-022-05731-4 · Cited by 108
“…of validation studies [28–30] Model Chowdhury et al [28]a Chowdhury et al [30]b Buchan et al [29]c CVD Stroke CV-related death MI Stroke UKPDS, Stevens et al, 2001 [34] 0.66 (0.60, 0.72) d UKPDS, Kothari et al, 2002 [33] d 0.72 (0.68, 0.75) UKPDS OM 1, Clarke et al, 2004 [31] 0.66 (0.61,…”
BackgroundResultInfluentialStåhlman, M., Pham, H. T., Adiels, M., Mitchell, T. W., Blanksby, S. J., Fagerberg, B., Ekroos, K., & Borén, J. (2012) · Diabetologia · doi:10.1007/s00125-011-2444-6 · Cited by 107
“Assessment of 10 year risk of coronary heart disease from lipid data The 10 year risk for CHD was calculated using the UK Prospective Diabetes Study (UKPDS) risk engine in the type 2 diabetic individuals [19].”
MethodLind, M., Odén, A., Fahlén, M., & Eliasson, B. (2010) · Diabetologia · doi:10.1007/s00125-010-1706-z · Cited by 107
“We have also shown that the use of updated mean HbA1c which does not consider the prolonged effect of HbA1c, probably leads to substantial underestimations of the predictive ability of HbA1c, a finding that is important in health economical analyses and risk engines [2, 27].”
BackgroundBalducci, S., Zanuso, S., Cardelli, P., Salvi, L., Mazzitelli, G., Bazuro, A., Iacobini, C., Nicolucci, A., Pugliese, G., & for the Italian Diabetes Exercise Study (IDES) Investigators (2012) · Diabetes Care · doi:10.2337/dc11-1859 · Cited by 100
Preventing Cardiovascular Disease and Diabetes
Eckel, R. H., Kahn, R., Robertson, R. M., & Rizza, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9911 · Cited by 95
Cichosz, S. L., Johansen, M. D., & Hejlesen, O. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815611680 · Cited by 101
“Several scores have been developed specifically to predict heart disease in patients with diabetes.(78-90) The AUC of these models ranges from 0.”
BackgroundCleveringa, F. G. W., Gorter, K. J., van den Donk, M., & Rutten, G. E. H. M. (2008) · Diabetes Care · doi:10.2337/dc08-0312 · Cited by 98
“Secondary outcomes were the 1-year difference in the 10-year UKPDS CHD risk estimate and the percentage of patients that reached A1C 7%, systolic blood pressure 140 mmHg, total cholesterol 4.5 mmol/l, and LDL cholesterol 2.5 mmol/l (6).”
MethodInfluentialPan, B., Wu, Y., Yang, Q., Ge, L., Gao, C., Xun, Y., Tian, J., & Ding, G. (2019) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12312 · Cited by 99
Aminian, A., Zajichek, A., Arterburn, D. E., Wolski, K. E., Brethauer, S. A., Schauer, P. R., Nissen, S. E., & Kattan, M. W. (2020) · Diabetes Care · doi:10.2337/dc19-2057 · Cited by 99
Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., Cherney, D. Z. I., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155931 · Cited by 103
Berkelmans, G. F. N., Gudbjörnsdottir, S., Visseren, F. L. J., Wild, S. H., Franzen, S., Chalmers, J., Davis, B. R., Poulter, N. R., Spijkerman, A. M., Woodward, M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy839 · Cited by 97
Aspirin for the Primary Prevention of Cardiovascular Events
Calvin, A. D., Aggarwal, N. R., Murad, M. H., Shi, Q., Elamin, M. B., Geske, J. B., Fernandez-Balsells, M. M., Albuquerque, F. N., Lampropulos, J. F., Erwin, P. J., et al. (2009) · Diabetes Care · doi:10.2337/dc09-1297 · Cited by 99
“We suggest first estimating the 10-year risk of coronary heart disease (23,24).”
BackgroundMetabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications
Sidiropoulos, P. I., Karvounaris, S. A., & Boumpas, D. T. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2397 · Cited by 100
“It has also been argued that current risk assessment algorithms such as the Framingham Heart Study calculator [41] and UK Prospective Diabetes Study risk model [42] largely capture the risk associated with MetS.”
The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology
Després, J.-P., Cartier, A., Côté, M., & Arsenault, B. J. (2008) · Annals of Medicine · doi:10.1080/07853890802004959 · Cited by 93
“Of course, the presence of classical risk factors such as dyslipidemia and hypertension will increase the cardiovascular risk associated with a given hyperglycemic state (38).”
BackgroundRen, X., Jiang, M., Han, L., & Zheng, X. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03689-x · Cited by 101
“Atherosclerosis is the major cause of CVD and stroke [4].”
BackgroundSandbaek, A., Griffin, S. J., Rutten, G., Davies, M., Stolk, R., Khunti, K., Borch-Johnsen, K., Wareham, N. J., & Lauritzen, T. (2008) · Diabetologia · doi:10.1007/s00125-008-1013-0 · Cited by 97
“UKPDS risk engine The estimated absolute ten year risk of coronary heart disease (CHD) was calculated using the previously published UKPDS risk engine (27).”
MethodDeficiencies of Cardiovascular Risk Prediction Models for Type 1 Diabetes
Zgibor, J. C., Piatt, G. A., Ruppert, K., Orchard, T. J., & Roberts, M. S. (2006) · Diabetes Care · doi:10.2337/dc06-0290 · Cited by 93
Lindgren, P., Lindström, J., Tuomilehto, J., Uusitupa, M., Peltonen, M., Jönsson, B., de Faire, U., Hellénius, M.-L., & The DPS Study Group (2007) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462307070286 · Cited by 97
Zajac, L. E., Klein, W. M. P., & McCaul, K. D. (2006) · Journal of Health Communication · doi:10.1080/10810730600637301 · Cited by 102
Classification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 112
Cull, C. A., Jensen, C. C., Retnakaran, R. R., & Holman, R. R. (2007) · Circulation · doi:10.1161/circulationaha.107.733428 · Cited by 96
“Systolic 128 (19) 140 (19) 129 (17) 144 (21)”
Cigarette smoking, smoking cessation, and diabetes
Tonstad, S. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.04.013 · Cited by 91
“[29] R.”
van Dieren, S., Peelen, L. M., Nöthlings, U., van der Schouw, Y. T., Rutten, G. E. H. M., Spijkerman, A. M. W., van der A, D. L., Sluik, D., Boeing, H., Moons, K. G. M., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-1960-0 · Cited by 94
“However, the UKPDS risk engine is, in principle, designed for all risk periods, including periods shorter than 10 years [8].”
BackgroundMethodInfluentialZarkogianni, K., Athanasiou, M., Thanopoulou, A. C., & Nikita, K. S. (2018) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2017.2765639 · Cited by 83
Ahn, C. H., Min, S. H., Lee, D.-H., Oh, T. J., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., Ha, J., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00191 · Cited by 91
Bellary, S., Paul O'Hare, J., Raymond, N. T., Mughal, S., Hanif, W. M., Jones, A., Kumar, S., & Barnett, A. H. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.490468 · Cited by 95
Enhancing diabetes care by adding a pharmacist to the primary care team
Ip, E. J., Shah, B. M., Yu, J., Chan, J., Nguyen, L. T., & Bhatt, D. C. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp120238 · Cited by 91
Forouhi, N. G., Menon, R. K., Sharp, S. J., Mannan, N., Timms, P. M., Martineau, A. R., Rickard, A. P., Boucher, B. J., Chowdhury, T. A., Griffiths, C., et al. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12625 · Cited by 100
Cederholm, J., Eeg-Olofsson, K., Eliasson, B., Zethelius, B., Gudbjörnsdottir, S., & Register, O. B. O. T. S. N. D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03342.x · Cited by 90
Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes
Menzaghi, C., Bacci, S., Salvemini, L., Mendonça, C., Palladino, G., Fontana, A., Bonis, C. D., Marucci, A., Goheen, E., Prudente, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064729 · Cited by 90
Optimizing the Start Time of Statin Therapy for Patients with Diabetes
Denton, B. T., Kurt, M., Shah, N. D., Bryant, S. C., & Smith, S. A. (2009) · Medical Decision Making · doi:10.1177/0272989x08329462 · Cited by 104
Risk of Cardiovascular Diseases Is Increased Even with Mild Diabetic Retinopathy
Kawasaki, R., Tanaka, S., Tanaka, S., Abe, S., Sone, H., Yokote, K., Ishibashi, S., Katayama, S., Ohashi, Y., Akanuma, Y., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.08.029 · Cited by 91
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J. M., Capodanno, D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.016 · Cited by 123
Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?
Stephens, J. W., Ambler, G., Vallance, P., Betteridge, D. J., Humphries, S. E., & Hurel, S. J. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200412000-00013 · Cited by 90
McEwan, P. C., Peters, J. R., Bergenheim, K., & Currie, C. J. (2005) · Current Medical Research and Opinion · doi:10.1185/030079906x80350 · Cited by 89
Fadini, G. P., Rigato, M., Cappellari, R., Bonora, B. M., & Avogaro, A. (2017) · Diabetes Care · doi:10.2337/dc16-1755 · Cited by 86
The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
Lind, M., Odén, A., Fahlén, M., & Eliasson, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004412 · Cited by 82
“The risk engines in use today are based on a mean value of two measurements, and the risk of a particular complication will thus probably be much lower than that given by an optimal variable [25].”
BackgroundThe independent relationship between triglycerides and coronary heart disease
Morrison, A. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4311 · Cited by 86
Derivation and Validation of a New Cardiovascular Risk Score for People With Type 2 Diabetes
Elley, C. R., Robinson, E., Kenealy, T., Bramley, D., & Drury, P. L. (2010) · Diabetes Care · doi:10.2337/dc09-1444 · Cited by 88
Jamthikar, A., Gupta, D., Saba, L., Khanna, N. N., Araki, T., Viskovic, K., Mavrogeni, S., Laird, J. R., Pareek, G., Miner, M., et al. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2020.01.07 · Cited by 83
Long-term outcomes from a multiple-risk-factor diabetes trial for Latinas: ¡Viva Bien!
Toobert, D. J., Strycker, L. A., King, D. K., Barrera, M., Osuna, D., & Glasgow, R. E. (2011) · Translational Behavioral Medicine · doi:10.1007/s13142-010-0011-1 · Cited by 83
An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study
Davis, W. A., Knuiman, M. W., & Davis, T. M. E. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.01958.x · Cited by 83
Donnan, P. T., Donnelly, L., New, J. P., & Morris, A. D. (2006) · Diabetes Care · doi:10.2337/dc05-1911 · Cited by 85
Variation in Diabetes Care Among States
Arday, D. R., Fleming, B. B., Keller, D. K., Pendergrass, P. W., Vaughn, R. J., Turpin, J. M., & Nicewander, D. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2230 · Cited by 84
“complications (25,26), some recent studies suggest that blood pressure (29) and blood lipid control (30,32,33) are at least equally important in preventing cardiovascular complications.”
BackgroundWebb, D., Khunti, K., Srinivasan, B., Gray, L., Taub, N., Campbell, S., Barnett, J., Henson, J., Hiles, S., Farooqi, A., et al. (2010) · Trials · doi:10.1186/1745-6215-11-16 · Cited by 82
Zethelius, B., Eliasson, B., Eeg‐Olofsson, K., Svensson, A., Guðbjörnsdóttir, S., & Cederholm, J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.05.037 · Cited by 87
“The UKPDS risk model [8,9] is most widely used and has been recommended for practice guidelines [12,13], although nowadays considered to have poor calibration in more recent samples of patients with type 2 diabetes [5,6,14–18].”
BackgroundMethodResultInfluentialHolman, R. R., Paul, S., Farmer, A., Tucker, L., Stratton, I. M., Neil, H. A. W., & on behalf of the AFORRD study group (2009) · Diabetologia · doi:10.1007/s00125-008-1179-5 · Cited by 81
“Lipid profiles were measured at entry and at 4 months, with CVD risks estimated using the UK Prospective Diabetes Study (UKPDS) risk engine.[21, 22]”
MethodSelf-citation
Metadata
- Authors
- STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M.
- Affiliations
- University of Oxford (GB)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2001-12-01
- Volume
- 101
- Issue
- 6
- Pages
- 671
- ISSN
- 0143-5221 (ISSN-L)
- OpenAlex
- W2117191092
- Cited by
- 1,084
- References
- 51
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 10 · 2023: 33 · 2022: 44 · 2021: 60 · 2020: 46 · 2019: 42 · 2018: 47 · 2017: 42 · 2016: 39 · 2015: 60 · 2014: 66 · 2013: 68 · 2012: 59
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- coronary artery disease, type 2 diabetes, cardiovascular risk prediction, risk prediction model, glycemia, systolic blood pressure, serum lipids, primary prevention, smoking, sex differences
- MeSH terms
- Adult, Blood Pressure, Coronary Disease, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Lipids, Male, Middle Aged, Risk Factors, Smoking, Models, Statistical, Survival Rate, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.